Development and evaluation of plumbagin loaded chitin hydrogel for the treatment of skin cancer
Authors:
- Akanksha NairANAkanksha Nair
- Sreeja C. NairSNSreeja C. Nair
- Asoke BanerjiABAsoke Banerji
- Raja BiswasRBRaja Biswas
- Ullas MonyUMUllas Mony
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 66
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR15777/TRM/120/81/2015)
This publication has 40 references indexed in Scilit:
- UV Radiation and the SkinInternational Journal of Molecular Sciences, 2013
- Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivoInternational Journal of Cancer, 2012
- Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomasCarcinogenesis, 2011
- Plumbagin promotes the generation of astrocytes from rat spinal cord neural progenitors via activation of the transcription factor Stat3Journal of Neurochemistry, 2010
- Validation of a Static Franz Diffusion Cell System for In Vitro Permeation StudiesAAPS PharmSciTech, 2010
- 5-Hydroxy-2-Methyl-1,4-Naphthoquinone, a Vitamin K3 Analogue, Suppresses STAT3 Activation Pathway through Induction of Protein Tyrosine Phosphatase, SHP-1: Potential Role in ChemosensitizationMolecular Cancer Research, 2010
- Non-invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of AdministrationJournal of Pharmaceutical Sciences, 2010
- Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431Biochemical and Biophysical Research Communications, 2008
- Targeting STAT3 affects melanoma on multiple frontsCancer and Metastasis Reviews, 2005
- Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG‐1 ovarian cancer cellsMolecular Carcinogenesis, 2003